Top Markets
Coin of the day
GI Innovation, Inc. GI Innovation, Inc.

GI Innovation, Inc.

358570
Rank in Stocks #15419
GI Innovation, Inc. specializes in the research and creation of... GI Innovation, Inc. specializes in the research and creation of biopharmaceutical products. Its current developmental portfolio features drug candidates G-101, G-102, G-301, and G-108. Founded by Jang Myoung-ho on July 19, 2017, the company's main operations are situated in Seoul, South Korea.
Share Price
$5.50
Market Cap
$353.53M
Change (1 day)
-2.69%
Change (1 year)
-50.82%
Country
KR
Trade GI Innovation, Inc. (358570)

Category

P/E ratio for GI Innovation, Inc. (358570)
P/E ratio as of 2026 TTM: 0
According to GI Innovation, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for GI Innovation, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
31.44 -
US
36.85 -
NL
-23.32 -
AU
-17.59 -
US
- -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.